Second Warrant. The Company shall promptly issue to ATAI the Second Warrant, in satisfaction of its obligations under Section 4.15(c) of the SPA.
Second Warrant. The Company shall prepare and file with the Commission, within thirty (30) days after the Second Closing Date, an amendment to the Registration Statement (the “Amendment”) to add to the Registration Statement the Registrable Securities issuable upon exercise of the Second Warrant. The Company shall use commercially reasonable efforts to cause the Amendment to be declared effective by the Commission within sixty (60) days after the Second Closing Date.
Second Warrant. Only if Somanetics receives shareholder approval required by the rules of The Nasdaq Stock Market with respect to the Second Warrant and the Common Shares issuable upon exercise of the Second Warrant, on the date Somanetics receives 510(k) clearance or approval of a PMA application from the FDA to market the Products in the United States, Somanetics shall issue to CORrestore a five-year warrant to purchase an additional 1,920,000 Somanetics Corporation Common Shares and shall issue to Wolfx & Xompany a five-year warrant to purchase an additional 180,000 Somanetics Corporation Common Shares, in substantially the form attached as Exhibit C (the "Second Warrant"). The per share exercise price for the Second Warrant shall equal $3.00. The warrants shall become exercisable to purchase the following aggregate number of Somanetics Common Shares at the time Somanetics' cumulative "net sales" of the Products reach the following levels: Aggregate Additional Net Sales Shares --------- ------ $5,000,000 233,330 $10,000,000 233,330 $20,000,000 233,340 $35,000,000 350,000 $55,000,000 466,000 $80,000,000 584,000 CORrestore may terminate the Licenses at any time within 120 days after the Second Warrant was otherwise issuable if Somanetics fails to receive shareholder approval required by the rules of The Nasdaq Stock Market with respect to the Second Warrant and the Common Shares issuable upon exercise of the Second Warrant by the date the Second Warrant is otherwise issuable. Notwithstanding any of the foregoing to the contrary, upon any termination of the Licenses pursuant to Section 1.11, (1) the portion of the Second Warrant that is exercisable at the date of termination of the Licenses shall continue to be exercisable for 90 days after such termination (or the remaining term of the First Warrant if such termination is pursuant to Section 1.11.5) and shall then expire and be cancelled, (2) the portion of the Second Warrant that
Second Warrant. DCTI will grant to @Home a warrant representing the right for a seven (7) year period to purchase an aggregate of One Hundred Thousand (100,000) shares of unrestricted DCTI Common Stock (the "Performance Warrant Shares") at an exercise price equal nineteen dollars and forty-eight cents ($19.48) per share. Such warrant shall be covered by the Registration Statement.
Second Warrant. On any date the Holder purchases Additional Shares pursuant to Paragraph 5(e)(i), the Holder shall receive a Common Stock purchase warrant, in the form attached hereto as Exhibit C (the "Second Warrant"), exercisable for an additional number of shares of Common Stock equal to the aggregate purchase price of Additional Shares paid by the Holder on such date, divided by $40.00, at an exercise price equal to 135% of the average Market Price for Shares of Common Stock for the five trading days immediately preceding the Holder Conversion Date.
Second Warrant. Separate and independent from the First Warrant, in consideration of Xxxxxx’ contributions as described herein, Personalis shall issue to Tempus within 10 days of the Effective Date, a warrant to purchase from Personalis up to four million six hundred nine thousand four hundred (4,609,400) shares of Common Stock at an exercise price equal to two dollars and fifty cents ($2.50) per share (the “Second Warrant” and, together with the First Warrant, the “Warrants”). The Second Warrant shall be exercisable for cash solely at the option of Tempus on or before December 31, 2025. The Second Warrant shall be substantially in the form attached hereto as Exhibit G.
Second Warrant. The Second Warrant shall have been executed and delivered by the Company, and CHRP shall have received the same.
Second Warrant. In connection with the execution and delivery of this Amendment No. 2 by the Lender and the Borrower, the Borrower shall issue to the Lender a three-year warrant to purchase 375,000 shares of Common Stock (the “Second Warrant”) in the form of Warrant attached hereto as Exhibit B and subject to the terms and conditions set forth therein. Notwithstanding anything to the contrary in this Amendment No. 2, the Second Warrant or any other Credit Document, the Second Warrant is not exercisable for, or controvertible into, any shares of Common Stock, and the Lender may not purchase any shares of Common Stock under the Second Warrant, prior to the Exercise Date (as defined in the Second Warrant).
Second Warrant. Simultaneous with the closing of the Second PIPE Financing (and regardless of whether or not Xxxxxx makes an election for Boeing to participate in the Second PIPE Financing), Xxxxxx shall issue to Wisk a warrant in the form attached hereto as Exhibit D exercisable for Xxxxxx’x common stock with a fair value of [***] Dollars ($[***]) at the date of issuance with a $[***] per share of common stock exercise price (the “Second Warrant”). Within thirty (30) days following the closing of the Second Boeing Investment and the issuance of the Second Warrant, subject to Xxxxxx’x reasonable cooperation and the execution by the Parties of an appropriate non-disclosure, confidentiality and non-use agreement for the purpose of an exchange of technical information, Boeing or one of its Affiliates shall provide Xxxxxx with [***]. Section 2.13 [***]. (a) [***]. (b) [***].
Second Warrant. The Company shall execute and deliver to Purchaser a warrant to purchase Seven Hundred Fifty Thousand (750,000) shares of the Company's Common Stock (the "Second Warrant"). The exercise price for the Second Warrant shall be Twenty Cents ($0.20) per share. Subject to the terms and conditions of the Second Warrant, the term of the Second Warrant shall be sixty (60) days from the date of grant.
